ATOSSA GENETICS ($ATOS) posted quarterly earnings results on Tuesday, March 25th. The company reported earnings of -$0.05 per share, beating estimates of -$0.06 by $0.01. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $ATOS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ATOSSA GENETICS Hedge Fund Activity
We have seen 35 institutional investors add shares of ATOSSA GENETICS stock to their portfolio, and 35 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 1,053,910 shares (+1488.7%) to their portfolio in Q4 2024, for an estimated $994,996
- CITADEL ADVISORS LLC added 265,921 shares (+164.3%) to their portfolio in Q4 2024, for an estimated $251,056
- RENAISSANCE TECHNOLOGIES LLC added 247,562 shares (+18.9%) to their portfolio in Q4 2024, for an estimated $233,723
- JPMORGAN CHASE & CO added 211,654 shares (+141.4%) to their portfolio in Q4 2024, for an estimated $199,822
- VIRTU FINANCIAL LLC added 157,549 shares (+311.1%) to their portfolio in Q4 2024, for an estimated $148,742
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 154,404 shares (+215.1%) to their portfolio in Q4 2024, for an estimated $145,772
- MARINER, LLC removed 105,910 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $160,983
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
